These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 20162697)

  • 1. Systemic rapamycin to prevent restenosis: a glimpse to the past?
    Belardi J
    Catheter Cardiovasc Interv; 2010 Feb; 75(3):326. PubMed ID: 20162697
    [No Abstract]   [Full Text] [Related]  

  • 2. Sirolimus-eluting vs uncoated stents for prevention of restenosis in small coronary arteries: a randomized trial.
    Ardissino D; Cavallini C; Bramucci E; Indolfi C; Marzocchi A; Manari A; Angeloni G; Carosio G; Bonizzoni E; Colusso S; Repetto M; Merlini PA;
    JAMA; 2004 Dec; 292(22):2727-34. PubMed ID: 15585732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delayed occurrence of restenosis in drug eluting stents: an evidence of delayed healing.
    Sapra R; Kaul U; Gupta RK; Kachru R; Ghose T; Sharma S; Parida AK; Samal MP; Singh B
    J Assoc Physicians India; 2005 May; 53():483-5. PubMed ID: 16124361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sirolimus-eluting stents for the prevention of restenosis in a worst-case scenario of diffuse and recurrent in-stent restenosis.
    Werner GS; Emig U; Krack A; Schwarz G; Figulla HR
    Catheter Cardiovasc Interv; 2004 Nov; 63(3):259-64. PubMed ID: 15505841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Choice of drug-eluting stents.
    Med Lett Drugs Ther; 2012 Dec; 54(1406):102-3. PubMed ID: 23282791
    [No Abstract]   [Full Text] [Related]  

  • 6. Intravascular ultrasound stent area of sirolimus-eluting stents and its impact on late outcome.
    Cheneau E; Pichard AD; Satler LF; Suddath WO; Weissman NJ; Waksman R
    Am J Cardiol; 2005 May; 95(10):1240-2. PubMed ID: 15878001
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-eluting stents.
    Whitlow P
    J Invasive Cardiol; 2004 Jul; 16(7 Suppl):2S-6S. PubMed ID: 23573564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary arteries: double-blind, randomised controlled trial (E-SIRIUS).
    Schofer J; Schlüter M; Gershlick AH; Wijns W; Garcia E; Schampaert E; Breithardt G;
    Lancet; 2003 Oct; 362(9390):1093-9. PubMed ID: 14550694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fracture of a paclitaxol-eluting stent implanted for in-stent restenosis at the site of sirolimus-eluting stent fracture.
    Watanabe T; Tamura A; Miyamoto K; Kadota J
    Int J Cardiol; 2010 Apr; 140(1):e12-3. PubMed ID: 19059662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Myocardial revascularization: the point in 2008].
    Guillevin L
    Presse Med; 2008 Nov; 37(11):1533-4. PubMed ID: 18848417
    [No Abstract]   [Full Text] [Related]  

  • 11. Images in cardiovascular medicine: Late abnormal vessel wall reaction 3 years after sirolimus-eluting stent implantation.
    Kawaguchi R; Jingu M; Yamashita E; Toyama T; Hoshizaki H; Oshima S
    Circulation; 2009 Sep; 120(9):e65. PubMed ID: 19720941
    [No Abstract]   [Full Text] [Related]  

  • 12. [Insulin-dependent. Rapamycin-resistant?].
    Sabaté M
    Rev Esp Cardiol; 2006 Feb; 59(2):91-3. PubMed ID: 16540028
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of C-reactive protein levels before and after coronary stenting and restenosis among patients treated with sirolimus-eluting versus bare metal stents.
    Dibra A; Ndrepepa G; Mehilli J; Dirschinger J; Pache J; Schühlen H; Schömig A; Kastrati A
    Am J Cardiol; 2005 May; 95(10):1238-40. PubMed ID: 15878000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sirolimus eluting stent fracture following angioplasty of diffuse in-stent restenosis in the right coronary artery.
    Wilczynska J; Rdzanek A; Kochman J; Horszczaruk GJ; Pietrasik A; Opolski G
    Int J Cardiol; 2007 May; 118(1):126-7. PubMed ID: 16908080
    [No Abstract]   [Full Text] [Related]  

  • 15. Restenosis of a sirolimus drug-eluting stent: aorto-ostial involvement of the proximal right coronary artery.
    Applegate RJ; Draughn T; Yarbrough WD; Little WC
    Catheter Cardiovasc Interv; 2006 Mar; 67(3):391-5. PubMed ID: 16475190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sirolimus-eluting stents vs brachytherapy for restenosis.
    Alfonso F; Sabate M
    JAMA; 2006 Oct; 296(15):1837-8; author reply 1838. PubMed ID: 17047209
    [No Abstract]   [Full Text] [Related]  

  • 17. [Drug-eluting stents: do they keep their promises?].
    Nordmann A
    Praxis (Bern 1994); 2006 Apr; 95(15):581-3. PubMed ID: 16640178
    [No Abstract]   [Full Text] [Related]  

  • 18. Sirolimus-eluting stent or paclitaxel-eluting stent vs balloon angioplasty for prevention of recurrences in patients with coronary in-stent restenosis: a randomized controlled trial.
    Kastrati A; Mehilli J; von Beckerath N; Dibra A; Hausleiter J; Pache J; Schühlen H; Schmitt C; Dirschinger J; Schömig A;
    JAMA; 2005 Jan; 293(2):165-71. PubMed ID: 15644543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stenting small coronary arteries: works in progress.
    Holmes DR
    JAMA; 2004 Dec; 292(22):2777-8. PubMed ID: 15585739
    [No Abstract]   [Full Text] [Related]  

  • 20. Sirolimus- and paclitaxel-eluting stents in comparison with balloon angioplasty for treatment of in-stent restenosis.
    Iofina E; Haager PK; Radke PW; Langenberg R; Blindt R; Ortlepp J; Kühl H; Hanrath P; Hoffmann R
    Catheter Cardiovasc Interv; 2005 Jan; 64(1):28-34. PubMed ID: 15619307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.